Literature DB >> 1689668

Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression.

C S Scott1, S J Richards, P S Master, J Kendall, H J Limbert, B E Roberts.   

Abstract

Blast cells from 26 cases of acute myeloid leukaemia (AML) were examined, by single and "two-colour" flow cytometry, for relationships between membrane CD11b (monoclonal antibody OKM1), CD11c (KB90) and CD14 (Leu-M3). Increased expression of all three determinants was associated with myelomonocytic leukaemias, with their relative diagnostic value in discriminating monocytic (M4 and M5) from non-monocytic (M1, M2 and M3) subtypes being CD14 greater than CD11c greater than CD11b. However, the results also indicated, because of the heterogenous expression of CD11c in particular, and to a lesser extent CD11b, that the patterns or histograms of fluorescent staining were potentially more informative than an empirical subdivision of blasts into positive and negative subpopulations. In addition, analysis of phenotypic correlations by simultaneous two-colour fluorescence showed that the expression of CD11b and CD11c determinants by leukaemic myeloid blasts was highly correlated, in contrast to the expression of CD14 and CD11c which were relatively independent. Consequently, CD11c+ myeloid blasts almost always coexpressed CD11b whereas CD14+ cases of AML often comprised CD14+ CD11c+ and CD14+ CD11c- subpopulations. It is concluded from these observations that CD11c immunophenotyping is a useful supplementary investigation, particularly in CD14- cases of myelomonocytic leukaemia. However, it is also apparent that the presence of membrane CD11c per se is not lineage-specific and that the level of expression is perhaps a more discriminatory factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689668     DOI: 10.1111/j.1600-0609.1990.tb00342.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.

Authors:  P S Master; S J Richards; J Kendall; B E Roberts; C S Scott
Journal:  Blut       Date:  1989-09

2.  Serum CD14 levels in polytraumatized and severely burned patients.

Authors:  C Krüger; C Schütt; U Obertacke; T Joka; F E Müller; J Knöller; M Köller; W König; W Schönfeld
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

3.  Association of Electronegative LDL with Macrophage Foam Cell Formation and CD11c Expression in Rheumatoid Arthritis Patients.

Authors:  Ching-Kun Chang; Po-Ku Chen; Joung-Liang Lan; Shih-Hsin Chang; Tsu-Yi Hsieh; Pei-Jyuan Liao; Chu-Huang Chen; Der-Yuan Chen
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

Review 4.  Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

Authors:  Liam J O'Brien; Camille Guillerey; Kristen J Radford
Journal:  Cancers (Basel)       Date:  2019-06-22       Impact factor: 6.575

5.  Annotation of genes having candidate somatic mutations in acute myeloid leukemia with whole-exome sequencing using concept lattice analysis.

Authors:  Kye Hwa Lee; Jae Hyeun Lim; Ju Han Kim
Journal:  Genomics Inform       Date:  2013-03-31

6.  Acute monocytic leukemia diagnosed by flow cytometry includes acute myeloid leukemias with weakly or faintly positive non-specific esterase staining.

Authors:  Yuriko Zushi; Miho Sasaki; Ayano Mori; Toshiharu Saitoh; Takae Goka; Yumi Aoyama; Yuta Goto; Hiroko Tsunemine; Taiichi Kodaka; Takayuki Takahashi
Journal:  Hematol Rep       Date:  2018-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.